| Schedule of Segment Information |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pharmaceutical |
|
|
|
|
|
|
|
|
and |
|
|
|
|
|
Dermatology |
|
Biotechnology |
|
|
|
|
|
Products |
|
Product |
|
|
|
Year Ended December 31, 2023 |
|
Sales |
|
Development |
|
Consolidated |
Net revenue |
|
$ |
79,181 |
|
$ |
5,332 |
|
$ |
84,513 |
Cost of goods - product revenue |
|
|
(26,660) |
|
|
— |
|
|
(26,660) |
Research and development |
|
|
(7,541) |
|
|
(98,530) |
|
|
(106,071) |
Selling, general and administrative |
|
|
(47,053) |
|
|
(47,071) |
|
|
(94,124) |
Other expense |
|
|
(1,559) |
|
|
(9,732) |
|
|
(11,291) |
Income tax expense |
|
|
(221) |
|
|
(300) |
|
|
(521) |
Segment loss |
|
$ |
(3,853) |
|
$ |
(150,301) |
|
$ |
(154,154) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pharmaceutical |
|
|
|
|
|
|
|
|
and |
|
|
|
|
|
Dermatology |
|
Biotechnology |
|
|
|
|
|
Products |
|
Product |
|
|
|
Year Ended December 31, 2022 |
|
Sales |
|
Development |
|
Consolidated |
Net revenue |
|
$ |
73,669 |
|
$ |
2,074 |
|
$ |
75,743 |
Cost of goods - product revenue |
|
|
(30,775) |
|
|
— |
|
|
(30,775) |
Research and development |
|
|
(10,943) |
|
|
(123,933) |
|
|
(134,876) |
Selling, general and administrative |
|
|
(59,503) |
|
|
(54,153) |
|
|
(113,656) |
Other expense |
|
|
(2,048) |
|
|
(7,852) |
|
|
(9,900) |
Income tax (expense) benefit |
|
|
— |
|
|
(449) |
|
|
(449) |
Segment loss |
|
$ |
(29,600) |
|
$ |
(184,313) |
|
$ |
(213,913) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pharmaceutical |
|
|
|
|
|
|
|
|
and |
|
|
|
($ in thousands) |
|
Dermatology |
|
Biotechnology |
|
|
|
|
|
Products |
|
Product |
|
|
|
December 31, 2023 |
|
Sales |
|
Development |
|
Total Assets |
Intangible assets, net |
|
$ |
20,287 |
|
$ |
— |
|
$ |
20,287 |
Tangible assets |
|
|
56,561 |
|
|
90,678 |
|
|
147,239 |
Total segment assets |
|
$ |
76,848 |
|
$ |
90,678 |
|
$ |
167,526 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pharmaceutical |
|
|
|
|
|
|
|
|
and |
|
|
|
($ in thousands) |
|
Dermatology |
|
Biotechnology |
|
|
|
|
|
Products |
|
Product |
|
|
|
December 31, 2022 |
|
Sales |
|
Development |
|
Total Assets |
Intangible assets, net |
|
$ |
27,197 |
|
$ |
— |
|
$ |
27,197 |
Tangible assets |
|
|
77,964 |
|
|
189,140 |
|
|
267,104 |
Total segment assets |
|
$ |
105,161 |
|
$ |
189,140 |
|
$ |
294,301 |
|